A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids

Lawrence J Cheskin, Paul J. Fudala, Rolley E. Johnson

Research output: Contribution to journalArticle

Abstract

We compared the short-term efficacy of a high-dose, 3 day regimen of buprenorphine to a standard 5-day course of clonidine in attenuating the signs and symptoms of the acute opioid abstinence syndrome during rapid detoxification from heroin in 25 men and women admitted to a closed inpatient research ward for this randomized, double-blind, parallel-group trial. Among the 18 completers, there were no significant differences between the buprenorphine and clonidine groups on five subjective and six physiological measures. However, clonidine lowered blood pressure and buprenorphine provided more effective early relief of withdrawal symptoms.

Original languageEnglish (US)
Pages (from-to)115-121
Number of pages7
JournalDrug and Alcohol Dependence
Volume36
Issue number2
DOIs
StatePublished - 1994

Fingerprint

Buprenorphine
Detoxification
Clonidine
Opioid Analgesics
withdrawal
Substance Withdrawal Syndrome
Group
Heroin
Blood pressure
Signs and Symptoms
Inpatients
Blood Pressure
Research

Keywords

  • Buprenorphine
  • Clonidine
  • Controlled trial
  • Detoxification
  • Opioid

ASJC Scopus subject areas

  • Medicine(all)
  • Behavioral Neuroscience
  • Toxicology
  • Health(social science)

Cite this

A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. / Cheskin, Lawrence J; Fudala, Paul J.; Johnson, Rolley E.

In: Drug and Alcohol Dependence, Vol. 36, No. 2, 1994, p. 115-121.

Research output: Contribution to journalArticle

Cheskin, Lawrence J ; Fudala, Paul J. ; Johnson, Rolley E. / A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. In: Drug and Alcohol Dependence. 1994 ; Vol. 36, No. 2. pp. 115-121.
@article{a9af4bef3ec24e24a6d6174ea945afde,
title = "A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids",
abstract = "We compared the short-term efficacy of a high-dose, 3 day regimen of buprenorphine to a standard 5-day course of clonidine in attenuating the signs and symptoms of the acute opioid abstinence syndrome during rapid detoxification from heroin in 25 men and women admitted to a closed inpatient research ward for this randomized, double-blind, parallel-group trial. Among the 18 completers, there were no significant differences between the buprenorphine and clonidine groups on five subjective and six physiological measures. However, clonidine lowered blood pressure and buprenorphine provided more effective early relief of withdrawal symptoms.",
keywords = "Buprenorphine, Clonidine, Controlled trial, Detoxification, Opioid",
author = "Cheskin, {Lawrence J} and Fudala, {Paul J.} and Johnson, {Rolley E.}",
year = "1994",
doi = "10.1016/0376-8716(94)90093-0",
language = "English (US)",
volume = "36",
pages = "115--121",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids

AU - Cheskin, Lawrence J

AU - Fudala, Paul J.

AU - Johnson, Rolley E.

PY - 1994

Y1 - 1994

N2 - We compared the short-term efficacy of a high-dose, 3 day regimen of buprenorphine to a standard 5-day course of clonidine in attenuating the signs and symptoms of the acute opioid abstinence syndrome during rapid detoxification from heroin in 25 men and women admitted to a closed inpatient research ward for this randomized, double-blind, parallel-group trial. Among the 18 completers, there were no significant differences between the buprenorphine and clonidine groups on five subjective and six physiological measures. However, clonidine lowered blood pressure and buprenorphine provided more effective early relief of withdrawal symptoms.

AB - We compared the short-term efficacy of a high-dose, 3 day regimen of buprenorphine to a standard 5-day course of clonidine in attenuating the signs and symptoms of the acute opioid abstinence syndrome during rapid detoxification from heroin in 25 men and women admitted to a closed inpatient research ward for this randomized, double-blind, parallel-group trial. Among the 18 completers, there were no significant differences between the buprenorphine and clonidine groups on five subjective and six physiological measures. However, clonidine lowered blood pressure and buprenorphine provided more effective early relief of withdrawal symptoms.

KW - Buprenorphine

KW - Clonidine

KW - Controlled trial

KW - Detoxification

KW - Opioid

UR - http://www.scopus.com/inward/record.url?scp=0027936994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027936994&partnerID=8YFLogxK

U2 - 10.1016/0376-8716(94)90093-0

DO - 10.1016/0376-8716(94)90093-0

M3 - Article

C2 - 7851278

AN - SCOPUS:0027936994

VL - 36

SP - 115

EP - 121

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 2

ER -